Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Niehaus Pharma is a specialized German pharmaceutical company focused on the marketing and distribution of over-the-counter (OTC) medications and medical devices. The company is best known for its Gelo brand family, which includes products like GeloMyrtol forte for respiratory tract infections and GeloRevoice for throat irritation. Headquartered in Ingelheim am Rhein, Niehaus Pharma serves the pharmacy-led self-medication market with a focus on ENT and respiratory health. Their portfolio combines standardized herbal extracts with modern delivery systems to provide symptomatic relief for common ailments. The company maintains a strong presence in the German healthcare market through evidence-based products and close cooperation with manufacturing partners. Niehaus Pharma emphasizes high quality and safety standards in the development and distribution of its therapeutic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Niehaus Pharma.